Trulieve Cannabis Corp.

TRLV ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Assets
Cash & Equivalents $255.5M $238.8M $201.4M $207.2M $226.6M $146.7M
Accounts Receivable $10.5M $8.3M $6.7M $6.5M $8.9M $308.0K
Inventory $242.3M $231.4M $213.1M $276.5M $212.2M $98.3M
Total Current Assets $562.7M $604.6M $477.3M $593.5M $524.4M $261.5M
Property, Plant & Equipment $670.4M $716.1M $676.4M $743.3M $779.9M $314.0M
Goodwill $483.9M $483.9M $483.9M $791.5M $765.4M $67.2M
Intangible Assets (Excl. Goodwill) $798.4M $859.5M $917.2M $984.8M $1.12B $92.6M
Total Assets $2.70B $2.87B $2.73B $3.40B $3.41B $809.8M
Liabilities
Accounts Payable $26.8M $20.2M $28.2M $15.9M $14.8M $9.2M
Total Current Liabilities $126.9M $138.5M $114.8M $210.3M $168.9M $76.1M
Long-Term Debt $136.7M $364.8M $363.2M $541.7M $462.9M —
Total Liabilities $1.55B $1.62B $1.32B $1.47B $1.26B $361.9M
Stockholders' Equity
Retained Earnings $-912.1M $-795.7M $-640.6M $-113.8M $137.7M $119.7M
Total Stockholders' Equity $1.14B $1.25B $1.41B $1.93B $2.15B $447.9M